ニューロサイエンスの市場規模、シェア、成長分析、コンポーネント別、技術別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

ニューロサイエンスの世界市場規模は2023年に405億米ドルとなり、予測期間（2025年～2032年）のCAGRは5.1%で、2024年の425億7,000万米ドルから2032年には633億7,000万米ドルに成長する見通しです。

世界のニューロサイエンス市場は、消費者行動のシフト、政府の取り組み、技術の進歩によって大きな成長が見込まれています。世界各国の当局は、スマートヘルスケアと認知診断を強化するため、ニューロデジタルインフラストラクチャへの投資を進めています。シンガポールでは、2024年までに本格展開されるウェアラブル脳波計とニューロフィードバック装置を組み込んだ全国的な神経データ分析プラットフォームによって、スマートヘルス構想が例証されています。これらのデバイスは、さまざまなヘルスケア環境における脳波活動やストレスレベルに関するリアルタイムの神経学的データを収集します。STエンジニアリングとニューロスカイのような官民パートナーシップの台頭により、2025年までメンタルヘルス問題のスクリーニングとモニタリングがさらに進むと予想されます。一方、機械学習とAIは超個人化治療を可能にし、5Gの普及は遠隔神経モニタリング機能を強化し、タイムリーな介入を向上させ、医療技術の持続可能性を促進します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 顧客購買行動分析

ニューロサイエンス市場規模：コンポーネント別& CAGR（2025年～2032年）

• 市場概要
• 機器
• 消耗品
• ソフトウェアとサービス

ニューロサイエンス市場規模：技術別& CAGR（2025年～2032年）

• 市場概要
• 脳画像
• 神経顕微鏡検査
• 定位固定手術
• 神経プロテオーム解析
• 神経細胞操作
• その他

ニューロサイエンス市場規模：エンドユーザー別& CAGR（2025年～2032年）

• 市場概要
• 病院
• 診断検査室
• 調査学術機関

ニューロサイエンス市場規模：地域別& CAGR（2025年～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Carl Zeiss AG
• Danaher Corporation
• GE Healthcare
• Siemens Healthcare Private Limited
• Koninklijke Philips N.V.
• Canon Inc.
• B. Braun SE
• Medtronic
• Stryker
• Boston Scientific Corporation
• ABBOTT
• Terumo Corporation

結論と提言

Global Neuroscience Market size was valued at USD 40.5 billion in 2023 and is poised to grow from USD 42.57 billion in 2024 to USD 63.37 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global neuroscience market is poised for significant growth driven by shifts in consumer behavior, government initiatives, and technology advancements. Authorities worldwide are investing in neuro-digital infrastructure to enhance smart healthcare and cognitive diagnostics. In Singapore, the Smart Health initiative is exemplified by a nationwide neural data analytics platform incorporating wearable EEG and neurofeedback devices, set for full deployment by 2024. These devices gather real-time neurological data on brainwave activity and stress levels in various healthcare settings. The rise of public-private partnerships, such as those between ST Engineering and NeuroSky, is expected to further advance screening and monitoring for mental health issues through 2025. Meanwhile, machine learning and AI are enabling hyper-personalized therapies, and the proliferation of 5G is enhancing remote neuro-monitoring capabilities, improving timely interventions and promoting sustainability in medical technology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuroscience market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuroscience Market Segments Analysis

Global Neuroscience Market is segmented by Component, Technology, End-user and region. Based on Component, the market is segmented into Instruments, Consumables and Software & Services. Based on Technology, the market is segmented into Brain Imaging, Neuro-Microscopy, Stereotaxic Surgeries, Neuro-Proteomic Analysis, Neuro-Cellular Manipulation and Others. Based on End-user, the market is segmented into Hospitals, Diagnostic laboratories and Research and Academic Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuroscience Market

The global neuroscience market is being significantly influenced by the integration of artificial intelligence (AI) and machine learning technologies in brain health management. These innovations enable real-time analysis of neural data, allowing for early recognition of patterns and customized cognitive therapy solutions that have transformed the field. Additionally, AI-driven applications, such as natural language processing (NLP) and computer vision algorithms, enhance the accuracy with which physicians interpret complex brain imaging and neurophysiological signals compared to traditional methods. The rise in popularity of AI-integrated brain-computer interfaces (BCIs) is also shaping neurorehabilitation, prosthetic control, and communication enhancements for patients with severe brain injuries.

Restraints in the Global Neuroscience Market

The Global Neuroscience market faces significant constraints due to the substantial financial investment required for acquiring, installing, calibrating, and maintaining advanced neuroscience technologies. Cutting-edge tools such as functional magnetic resonance imaging (fMRI), magnetoencephalography (MEG) systems, electrocorticography (ECoG), brain-computer interfaces (BCIs), and high-resolution neuroimaging platforms demand considerable resources, making them costly for research institutions and healthcare facilities. This financial barrier can limit accessibility and hinder widespread adoption of these critical technologies, potentially slowing advancements in neuroscience research and clinical applications. As a result, the high costs associated with these sophisticated tools pose a notable challenge to the industry's growth.

Market Trends of the Global Neuroscience Market

The Global Neuroscience market is experiencing a significant transformation driven by the integration of AI-powered precision diagnostics and programmatic decision-making. Similar to how programmatic advertising reshaped digital marketing, AI-driven analytics are enhancing neuroscience diagnostics through predictive modeling, automated neural image processing, and advanced EEG interpretation. This shift enables real-time, data-informed decisions, which optimize treatment protocols, streamline clinical workflows, and enhance diagnostic accuracy by adapting strategies based on immediate neural feedback. As a result, leading healthcare providers and med-tech innovators now regard widespread AI integration as a vital strategy for improving patient outcomes and increasing the efficiency of clinical interventions within the neuroscience sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Neuroscience Market Size by Component & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables
• Software & Services

Global Neuroscience Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Brain Imaging
• Neuro-Microscopy
• Stereotaxic Surgeries
• Neuro-Proteomic Analysis
• Neuro-Cellular Manipulation
• Others

Global Neuroscience Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic laboratories
• Research and Academic Institute

Global Neuroscience Market Size & CAGR (2025-2032)

• North America (Component, Technology, End-user)
  • US
  • Canada
• Europe (Component, Technology, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Technology, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Technology, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Technology, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Carl Zeiss AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare Private Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABBOTT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations